Fournier gangrene: Difference between revisions

No edit summary
(19 intermediate revisions by 7 users not shown)
Line 1: Line 1:
==Background==
==Background==
[[File:Gray1144.png|thumb|Scrotal anatomy]]
[[File:Figure 28 01 02.jpg|thumb|Scrotal anatomy]]
*Life-threatening polymicrobial necrotizing fasciitis of perineum, genitalia, or perianal area.
*Life-threatening polymicrobial necrotizing fasciitis of perineum, genitalia, or perianal area.
**Mostly bacteria lower GI system - [[B. fragilis]] and [[E. coli]]
**Obliterative endarteritis of subcutaneous arterioles leads to gangrene of overlying skin<ref name="Shyam">Shyam DC, Rapsang AG. Fournier's gangrene. Surgeon. 2013 Aug;11(4):222-32. doi: 10.1016/j.surge.2013.02.001.</ref>
**Obliterative endarteritis of subcutaneous arterioles leads to gangrene of overlying skin<ref name="Shyam">Shyam DC, Rapsang AG. Fournier's gangrene. Surgeon. 2013 Aug;11(4):222-32. doi: 10.1016/j.surge.2013.02.001.</ref>
*Risk Factors
**Diabetes mellitus (most common)
**Hypertension
**Alcoholism
**Advanced age
**Para/Quadriplegic
*M>F (10:1)<ref name="Shyam" />, (likely under-diagnosed in women<ref name="Concepts">Wróblewska M et al. Fournier's gangrene: current concepts. Pol J Microbiol. 2014;63(3):267-73.</ref>)
*Mortality - often cited as 20-40%, but up to 80% in some studies<ref name="Concepts" />
*Mortality - often cited as 20-40%, but up to 80% in some studies<ref name="Concepts" />
===Risk Factors===
*[[Diabetes mellitus]] (most common)
*[[Hypertension]]
*[[Alcoholism]]
*Advanced age
*Para/Quadriplegic
*Males>Females (10:1)<ref name="Shyam" />, (likely under-diagnosed in women<ref name="Concepts">Wróblewska M et al. Fournier's gangrene: current concepts. Pol J Microbiol. 2014;63(3):267-73.</ref>)


==Clinical Features==
==Clinical Features==
[[File:Fournier-Gangrene.png|thumb|Fournier's Gangrene]]
[[File:PMC3560168 JCAS-5-273-g004.png|thumb|ournier's Gangrene]]
*Initial event is usually local trauma or extension of a UTI or perianal infection<ref name="Shyam" />
*Initial event is usually local trauma or extension of a UTI or perianal infection<ref name="Shyam" />
**Gangrene develops over 2-7 days
**Gangrene develops over 2-7 days
Line 17: Line 23:
*Fever
*Fever
*Malodorous purulent drainage
*Malodorous purulent drainage
*In late or severe cases, pt may present in septic shock
*In late or severe cases, patient may present in septic shock


==Differential Diagnosis==
==Differential Diagnosis==
{{Template:Testicular DDX}}
{{Template:Testicular DDX}}


==Diagnosis==
==Evaluation==
'''Clinical diagnosis, based on history and physical exam'''
 
===Work-up===
===Work-up===
*CBC
*CBC - very elevated leukocytosis
*CMP
*CMP - hyponatremia
*ESR
*CRP
*CRP
*Lactate
*Lactate
Line 35: Line 40:
*CT Abdomen/pelvis (only if diagnosis unclear or if requested by surgery/urology)
*CT Abdomen/pelvis (only if diagnosis unclear or if requested by surgery/urology)


==Treatment==
===Evaluation===
*Clinical diagnosis, based on history and physical exam
*LRINEC score here: [[Necrotizing fasciitis]]
 
==Management==
*Immediate surgery and urology consult for surgical debridement (gangrene can spread at rate of 2-3 cm/hr<ref name="Shyam" />)
*Immediate surgery and urology consult for surgical debridement (gangrene can spread at rate of 2-3 cm/hr<ref name="Shyam" />)
*[[Antibiotics]] - Must cover [[gram positive]], [[gram negative]], and [[anaerobes]]
*[[Antibiotics]] - Must cover [[gram positive]], [[gram negative]], and [[anaerobes]]
**[[Vancomycin]] + ([[imipenem]] 1gm IV q24hr OR [[meropenem]] 500mg-1gm IV q8hr)
**[[Vancomycin]] + ([[imipenem]] 1gm IV q24hr '''OR''' [[meropenem]] 500mg-1gm IV q8hr '''OR''' [[piperacillin-tazobactam]] 3.375gm to 4.5gm IV q6h) +/- ([[clindamycin]] 600mg-900mg IV q8h '''OR''' [[metronidazole]] 1gm IV then 500mg IV q8h)
*Aggressive supportive care, including fluid resuscitation (and [Vasopressors|pressors], if indicated)
**[[Piperacillin-Tazobactam]] 3.375-4.5g q6hr and [[linezolid]] 600mg q12hr is an alternative regimen<ref>Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America [published correction appears in Clin Infect Dis. 2015 May 1;60(9):1448. Dosage error in article text]. Clin Infect Dis. 2014;59(2):e10-e52. doi:10.1093/cid/ciu444</ref>
*Aggressive supportive care, including fluid resuscitation (and [[Vasopressors|pressors]], if indicated)


==Disposition==
==Disposition==
Line 54: Line 64:


[[Category:ID]]
[[Category:ID]]
[[Category:GU]]
[[Category:Urology]]

Revision as of 01:37, 9 February 2021

Background

Scrotal anatomy
Scrotal anatomy
  • Life-threatening polymicrobial necrotizing fasciitis of perineum, genitalia, or perianal area.
    • Mostly bacteria lower GI system - B. fragilis and E. coli
    • Obliterative endarteritis of subcutaneous arterioles leads to gangrene of overlying skin[1]
  • Mortality - often cited as 20-40%, but up to 80% in some studies[2]

Risk Factors

Clinical Features

Fournier's Gangrene
ournier's Gangrene
  • Initial event is usually local trauma or extension of a UTI or perianal infection[1]
    • Gangrene develops over 2-7 days
  • Marked pain, localized swelling, crepitus, ecchymosis to genital or perineal area.
  • Fever
  • Malodorous purulent drainage
  • In late or severe cases, patient may present in septic shock

Differential Diagnosis

Testicular Diagnoses

Evaluation

Work-up

  • CBC - very elevated leukocytosis
  • CMP - hyponatremia
  • ESR
  • CRP
  • Lactate
  • Type and Screen
  • Wound Culture
  • Blood Cultures
  • CT Abdomen/pelvis (only if diagnosis unclear or if requested by surgery/urology)

Evaluation

Management

Disposition

  • Admit to ICU

See Also

References

  1. 1.0 1.1 1.2 1.3 Shyam DC, Rapsang AG. Fournier's gangrene. Surgeon. 2013 Aug;11(4):222-32. doi: 10.1016/j.surge.2013.02.001.
  2. 2.0 2.1 Wróblewska M et al. Fournier's gangrene: current concepts. Pol J Microbiol. 2014;63(3):267-73.
  3. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America [published correction appears in Clin Infect Dis. 2015 May 1;60(9):1448. Dosage error in article text]. Clin Infect Dis. 2014;59(2):e10-e52. doi:10.1093/cid/ciu444